Blood Advances

Aims & Scope

Blood Advances provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.

The journal covers all aspects of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology.

All articles undergo a rigorous peer-review and are selected on the basis of the originality of the findings, the superior quality of the work described, and the clarity of presentation.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Preservation url
• Apc url
• License

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 3,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism

  Citation: 1046

  Authors: Thomas L., Ignacio, Walter, Rebecca, Nathan P., Adam, Barbara A., Michael R., Veena, Sam, Caitlin, Suresh, Peter, Daniel M., Ivan, Ariel, Robby, Stephanie, Holger, Wojtek, Yuan, Yuqing

• American Society of Hematology 2019 guidelines for immune thrombocytopenia

  Citation: 978

  Authors: Cindy, Deirdra R., Donald M., George, Douglas B., Nichola, Adam, Jenny M., James N., Rachael F., Thomas, David J., Wendy, Keith R., Barbara, Hayley, Sara K.

• Updated international consensus report on the investigation and management of primary immune thrombocytopenia

  Citation: 833

  Authors: Drew, Donald M., James B., Beng H., Nichola, Terry, Waleed, Bertrand, Tomás José, John, Ming, Caroline, Vickie, Marc, Adrian C., Sue, Francesco, Marie, Yoshiaki, Raymond S., Francesco, David J.

• American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

  Citation: 647

  Authors: Gary H., Marc, Cihan, Marcello, Lisa K., Alok A., Andrew D., Agnes Y. Y., Fergus, Rebecca L., Simon, Elizabeth A., David, Wojtek, Lara A., Pablo

• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

  Citation: 598

  Authors: Holger J., Mary, Allison E., Susan R., Jan, Frederick A., Suely M., Neil A., Kenneth A., Francesco, Jill, Sara, Andrea, Gian Paolo, Ignacio, Robby, Juan J., Yuan, Wojtek

• American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

  Citation: 560

  Authors: Adam, Gowthami M., Beng H., Douglas B., Andreas, Yves, Lori A., Stephen B., Sixten, Theodore E., Ashleigh, Reem A., Rebecca L., Nancy

• American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients

  Citation: 452

  Authors: David R., Gian Paolo, Carole, Francesco, Charles W., David A., Susan R., Maryam, Anita, Frederick B., Maureen A., Kari A. O., Adolph J., Tejan, Sara, Jan L., Itziar Etxeandia-, Herman, Ignacio, Wojtek, Juan José, Holger J., Philipp

• American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy

  Citation: 448

  Authors: Shannon M., Anita, Saskia, Claire, Marc A., Andra H., Sara R., Ian A., John J., Meha, Nicole, Danielle, Andrea, Bram

• American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy

  Citation: 419

  Authors: Daniel M., Robby, Nathan P., Jack, Anne, Jane, Nadine, Juliet, Tarra, Francesco, Mark A., Arnav, Meha, Rasha, John J., Yuan, Gordon

• ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

  Citation: 408

  Authors: Paula D., Nathan T., Barbara, Jorge, Jeroen, Nicolas, Sandra, Vicki, Barbara, Claire, Simon, Robert, James S., Nikole, Robert, Veronica H., Nedaa, Mohamad A., Reem A.